Ionis Pharmaceuticals (IONS) Other Non-Current Liabilities (2010 - 2026)

Ionis Pharmaceuticals' Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $28.4 million for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities fell 51.87% year-over-year to $28.4 million; the TTM figure through Jun 2026 stood at $28.4 million (down 51.87% YoY), while the FY2025 annual figure was $28.1 million, down 45.85% from the prior year.
• Other Non-Current Liabilities for Q2 2026 stood at $28.4 million, up from $28.3 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $538.1 million in Q3 2024, with the low at $28.1 million in Q4 2025.
• The 4-year median for Other Non-Current Liabilities is $282.1 million (2023), against an average of $279.9 million.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities rose 4.95% in 2024, then plunged 94.65% in 2025.
• Ionis Pharmaceuticals' Other Non-Current Liabilities stood at $513.7 million in 2023, then sank by 89.89% to $51.9 million in 2024, then slumped by 45.85% to $28.1 million in 2025, then advanced by 1.13% to $28.4 million in 2026.
• Business Quant data shows IONS's Other Non-Current Liabilities at $28.4 million in Q2 2026, $28.3 million in Q1 2026, and $28.1 million in Q4 2025.